Why Do 9 of the Top 10 Global Pharma Companies Partner with Us?
...Because Life-enhancing Therapies Require Exceptional Solutions!
Truly innovative therapeutics are built on advanced science, disruptive technology, and reliable partnerships. From vaccines to cell and gene therapies, Eurofins Viracor BioPharma is a unique development partner with proven expertise across a broad array of industry-leading analytical technologies, providing integrated testing solutions to help advance your pioneering treatments to patients faster.
We are a team of highly experienced scientists and professionals, providing complex testing and assay development for clinical research. We offer broad experience in molecular infectious disease and immunogenicity testing, along with immune response monitoring, vaccine safety/efficacy assessment, and disease-associated biomarker testing.
At Eurofins Viracor BioPharma, we are dedicated to helping bring new therapies to market by providing high-quality, accurate results to our pharmaceutical partners, across multiple phases of drug development. Every day our team works collaboratively with our sponsor partners to solve some of the toughest bioassay challenges, leveraging the unique combination of state-of-the-art technology, and specialized expertise, that drug development companies have come to rely on for their clinical study needs.
Eurofins Viracor BioPharma Building Bridges
With Cutting edge technology and a specialized team of R&D scientists, Eurofins Viracor BioPharma has been supporting clients through multiple phases of drug development for over thirty-five years.
We’re experts in developing, customizing, and validating assays for complex clinical research testing. Our broad laboratory capabilities offer services covering infectious disease, immune response, allergy hypersensitivity, oncology, and more.
News and Events
See our latest news and upcoming events!